against-the-background-of-the-scandal-with-disabled-prosecutors-mp-tells-about-an-attempt-to-increase-the-salary-costs-for-prosecutors-at-a-record-level

Against the background of the scandal with “disabled” prosecutors: MP tells about an attempt to increase the salary costs for prosecutors at a record level

 • 118176 переглядiв

The draft State Budget for 2025 includes an additional UAH 2.7 billion for prosecutors' salaries. This means a record increase in the prosecutor's salary fund, despite the fact that the number of prosecutors has not increased significantly, and the state budget needs to be revised as never before. The details of this situation were reported in a commentary to UNN by Nina Yuzhanina, a member of the Verkhovna Rada's Finance Committee, MP.

According to her, MPs are currently working on amendments to the draft state budget for next year. And at yesterday's meeting of the working group, MP Yuzhanina made her proposals to reduce spending on prosecutorial activities.

"It was proposed to reduce expenditures on prosecutorial activities in terms of general fund salaries - 2 billion 744 million, and another item of expenditure - 172 million. That is, in fact, the salaries of prosecutors only, this is without SAPO prosecutors, were planned to be increased by 2.7 billion," explained the MP.

More than two thousand proposals were submitted to the draft State Budget by MPs09.10.24, 16:25 • [views_11040]

Yuzhanina also noted that prosecutors' salaries are steadily increasing from year to year and explained how this happens.

"The prosecutor's salary consists of several parts, the basis being, of course, the official salary. The official salary is tied to the subsistence minimum for able-bodied persons, the amount of this subsistence minimum is set as of January 1 of the calendar year. This is Article 7 of the State Budget.

And now (I will explain - ed.) what manipulation is taking place. In 2020, the official salary of a prosecutor of the District Prosecutor's Office was 15 subsistence minimums for able-bodied persons. Why do I use 2020? Because if you take this Article 7 of the state budget for 2020, it clearly states the subsistence level for able-bodied persons - UAH 2102. And the official salary was formed from UAH 2102 - 15 subsistence minimums. 31 thousand 530. They also have various allowances, bonuses, etc. Then, starting from January 1, 2021, the official salary consisted of 20 subsistence minimums, and from January 1, 2022 - 25 subsistence minimums. When all these increases took place, the state budget itself allocated a lower subsistence level for prosecutors and made an exception - UAH 1600, because they were catching up with this difference by raising the number of subsistence levels, and they were raising it so much that every year we had an increase in spending on the prosecutor's office. I took a few years, in 20 there were 5.7 billion for salaries, in 23 there were already 10 billion for salaries. What is happening now for 2025 is that they are adding another 2.7 billion," the MP explained.

She added that the Prosecutor General's Office had filed a request with the Ministry of Finance and the agency supported the request to return the calculations of prosecutors' salaries based on the minimum subsistence level of UAH 2,102. She noted that currently the salary of a district prosecutor is UAH 68 thousand.

According to Yuzhanina, the working group supported the proposal to reduce the prosecutors' payroll by UAH 2.7 billion. However, this happened against the backdrop of information about "disabled" prosecutors from the Khmelnytsky Prosecutor's Office.

Prosecutors of Khmelnytskyi region to be checked on the legality of disability granting16.10.24, 17:21 • [views_15469]

"When I started that discussion (at the working group meeting - ed.), there were 10 minutes of silent negotiations, everyone was talking to the person sitting next to them, because everyone was in a daze about what was happening with the prosecutor's office expenses. There was some kind of manipulation, apparently no one thought that we would start to look into it. And at the moment when we were meeting, information about "disabled" prosecutors in Khmelnytskyi appeared, and everyone understood that if I put this amendment to the floor for consideration, everyone would support it, to reduce labor costs by 2.7 billion. That's why this amendment was taken into account, but it was taken into account only at the working group," said the MP.

According to her, the Prosecutor General is planning to attend the meeting of the Verkhovna Rada committee, and she does not know what the fate of the proposal to reduce spending will be.

"So far, I don't see any possibility that this proposal of the working group will survive, because it still has to be voted on by the relevant committee, then by the parliament, then sent to the government for preparation for the second reading... I understand that there is no desire to cut spending at all. For example, the possibility of awarding bonuses of 40% of the salary to judges was also prescribed, and UAH 1.5 billion was allocated for all these bonuses," Yuzhanina said.

State Budget 2025 to be voted on at the end of November - head of the committee09.10.24, 10:53 • [views_41631]

According to the MP, she has submitted amendments to reduce various types of expenditures by more than UAH 99.6 billion. But will it be possible to achieve such a reduction? The MP is not sure, as she does not see a great desire to actually cut state budget expenditures.

Recall

The Prosecutor General has ordered an internal investigation into prosecutors in Khmelnytsky region over information about unlawful disability claims. The investigation will cover 50 prosecutors and other prosecutorial bodies.

Popular

Sleight of hand and no fraud, or how to save the profits of drug manufacturers Фармацевтичний ринок – один з найбільш зарегульованих у світі. З одного боку, це захищає споживачів від неякісної продукції та шахрайства. З іншого боку, зарегульованість може використовуватись і для захисту інтересів великих фармацевтичних компаній. Одним з таких інструментів є патентний захист. Патент дає компанії ексклюзивні права на виробництво та продаж певного лікарського засобу протягом певного періоду часу, зазвичай 20 років. Це дозволяє компанії встановлювати високі ціни на ліки, щоб компенсувати витрати на дослідження та розробку. Після закінчення терміну дії патенту, інші компанії можуть починати виробництво генериків – копій оригінального лікарського засобу. Генерики зазвичай дешевші за оригінальні ліки, що робить їх доступнішими для споживачів. Однак, фармацевтичні компанії часто використовують різні стратегії, щоб продовжити термін дії патентного захисту своїх ліків. Однією з таких стратегій є подання нових патентів на незначні зміни в лікарському засобі, такі як зміна форми випуску або дозування. Так зване «вічнозелене патентування». Це дозволяє компанії продовжувати отримувати високі прибутки від продажу ліків, навіть після закінчення терміну дії оригінального патенту. Іншою стратегією є укладання угод з виробниками генериків, щоб ті не випускали генерики на ринок. Так звані «pay-for-delay» угоди. Фармацевтична компанія платить виробнику генериків, щоб той відклав випуск генерика на певний період часу. Такі угоди є незаконними в багатьох країнах, але вони все ще зустрічаються на практиці. Обидві ці стратегії призводять до того, що споживачі змушені переплачувати за ліки. В Україні, як і в багатьох інших країнах, патентний захист фармацевтичної продукції є досить суворим. Це з одного боку стимулює інновації, але з іншого боку робить ліки менш доступними для населення. Для вирішення цієї проблеми, необхідно збалансувати інтереси фармацевтичних компаній та споживачів. З одного боку, необхідно забезпечити компаніям можливість отримувати прибуток від своїх інновацій. З іншого боку, необхідно зробити ліки більш доступними для населення. Одним з можливих рішень є посилення контролю за видачею патентів на фармацевтичну продукцію. Патентні відомства повинні більш ретельно перевіряти, чи є заявлені зміни в лікарському засобі дійсно інноваційними, чи вони є лише спробою продовжити термін дії патентного захисту. Іншим можливим рішенням є посилення контролю за укладанням угод між фармацевтичними компаніями та виробниками генериків. Антимонопольні органи повинні більш ретельно розслідувати такі угоди, щоб запобігти зловживанням. Крім того, необхідно розвивати виробництво генериків в Україні. Це дозволить знизити ціни на ліки та зробити їх більш доступними для населення. В цілому, для вирішення проблеми доступності ліків в Україні, необхідний комплексний підхід, який включає в себе посилення контролю за патентним захистом, боротьбу зі зловживаннями на фармацевтичному ринку та розвиток виробництва генериків. The pharmaceutical market is one of the most regulated in the world. On the one hand, this protects consumers from substandard products and fraud. On the other hand, regulation can also be used to protect the interests of large pharmaceutical companies. One such tool is patent protection. A patent gives a company exclusive rights to manufacture and sell a particular drug for a certain period of time, usually 20 years. This allows the company to set high prices for the drug to recoup its research and development costs. After the patent expires, other companies can begin producing generics – copies of the original drug. Generics are usually cheaper than original drugs, making them more accessible to consumers. However, pharmaceutical companies often use various strategies to extend the term of patent protection for their drugs. One such strategy is to file new patents on minor changes to the drug, such as changing the dosage form or dosage. This is so-called "evergreening." This allows the company to continue to generate high profits from the sale of the drug, even after the original patent expires. Another strategy is to make agreements with generic manufacturers not to release generics to the market. These are so-called "pay-for-delay" agreements. The pharmaceutical company pays the generic manufacturer to delay the release of the generic for a certain period of time. Such agreements are illegal in many countries, but they still occur in practice. Both of these strategies result in consumers being forced to overpay for medicines. In Ukraine, as in many other countries, patent protection for pharmaceutical products is quite strict. On the one hand, this encourages innovation, but on the other hand, it makes medicines less accessible to the population. To solve this problem, it is necessary to balance the interests of pharmaceutical companies and consumers. On the one hand, it is necessary to ensure that companies can profit from their innovations. On the other hand, it is necessary to make medicines more accessible to the population. One possible solution is to strengthen control over the issuance of patents for pharmaceutical products. Patent offices should more thoroughly check whether the claimed changes in the drug are truly innovative, or whether they are just an attempt to extend the term of patent protection. Another possible solution is to strengthen control over the conclusion of agreements between pharmaceutical companies and generic manufacturers. Antimonopoly authorities should more thoroughly investigate such agreements to prevent abuses. In addition, it is necessary to develop the production of generics in Ukraine. This will reduce the prices of medicines and make them more accessible to the population. In general, to solve the problem of access to medicines in Ukraine, a comprehensive approach is needed, which includes strengthening control over patent protection, combating abuses in the pharmaceutical market, and developing the production of generics.

 • 12422 переглядiв

Elon Musk said he regrets some of his posts about Trump

 • 41677 переглядiв

NATO seeks to include funds for Ukraine in new spending target - Bloomberg

 • 35319 переглядiв

News by theme

OSZAR »
OSZAR »